Stanczyk FZ - Search Results

1

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer.

Coelingh Bennink HJT, Schultz IJ, Schmidt M, Jordan VC, Briggs P, Egberts JFM, Gemzell-Danielsson K, Kiesel L, Kluivers K, Krijgh J, Simoncini T, Stanczyk FZ, Langer RD. Coelingh Bennink HJT, et al. Among authors: stanczyk fz. Breast Cancer Res. 2023 May 30;25(1):60. doi: 10.1186/s13058-023-01661-0. Breast Cancer Res. 2023. PMID: 37254150 Free PMC article. Review.

2

Progesterone and not estrogens or androgens causes breast cancer.

Coelingh Bennink HJT, Stanczyk FZ. Coelingh Bennink HJT, et al. Among authors: stanczyk fz. Climacteric. 2024 Apr;27(2):217-222. doi: 10.1080/13697137.2023.2292073. Epub 2024 Jan 10. Climacteric. 2024. PMID: 38197401 No abstract available.

3

Endometrial safety of low-dose vaginal estrogens.

Stanczyk FZ, Mandelbaum RS, Matharu H, Dancz CE, Sherman ME. Stanczyk FZ, et al. Menopause. 2023 Jun 1;30(6):650-658. doi: 10.1097/GME.0000000000002177. Epub 2023 Apr 4. Menopause. 2023. PMID: 37022294

4

The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women.

Chen IJ, Shoupe D, Karim R, Stanczyk FZ, Kono N, Sriprasert I, Hodis HN, Mack WJ. Chen IJ, et al. Among authors: stanczyk fz. Menopause. 2023 Jul 1;30(7):692-702. doi: 10.1097/GME.0000000000002192. Epub 2023 May 16. Menopause. 2023. PMID: 37192828 Clinical Trial.

5

Comparative estrogen exposure from compounded transdermal estradiol creams and Food and Drug Administration-approved transdermal estradiol gels and patches.

Newman MS, Saltiel D, Smeaton J, Stanczyk FZ. Newman MS, et al. Among authors: stanczyk fz. Menopause. 2023 Nov 1;30(11):1098-1105. doi: 10.1097/GME.0000000000002266. Epub 2023 Oct 18. Menopause. 2023. PMID: 37847876

6

Assessing estrogen exposure from transdermal estradiol patch therapy using a dried urine collection and a GC-MS/MS assay.

Newman MS, Mayfield BP, Saltiel D, Stanczyk FZ. Newman MS, et al. Among authors: stanczyk fz. Steroids. 2023 Jan;189:109149. doi: 10.1016/j.steroids.2022.109149. Epub 2022 Nov 19. Steroids. 2023. PMID: 36414155 Free article.

7

Comparison of estrogenic components used for hormonal contraception.

Stanczyk FZ, Winer SA, Foidart JM, Archer DF. Stanczyk FZ, et al. Contraception. 2024 Feb;130:110310. doi: 10.1016/j.contraception.2023.110310. Epub 2023 Oct 18. Contraception. 2024. PMID: 37863464 Review.

8

Early Life Anti-Müllerian Hormone Trajectories in Infant Girls.

Chin HB, Krall JR, Goldberg M, Stanczyk FZ, Darge K, Stallings VA, Rogan WJ, Umbach DM, Baird DD. Chin HB, et al. Among authors: stanczyk fz. Epidemiology. 2023 Jul 1;34(4):568-575. doi: 10.1097/EDE.0000000000001610. Epub 2023 Mar 16. Epidemiology. 2023. PMID: 36943795

9

Biosynthesis of estetrol in human pregnancy: Potential pathways.

Stanczyk FZ, Archer DF. Stanczyk FZ, et al. J Steroid Biochem Mol Biol. 2023 Sep;232:106359. doi: 10.1016/j.jsbmb.2023.106359. Epub 2023 Jun 28. J Steroid Biochem Mol Biol. 2023. PMID: 37390976

10

Quantitation of 5α-androstanedione in normal women and women with PCOS.

Stanczyk FZ, Mandelbaum R, Baker M, Ma L, Sriprasert I, Dancz CE, Legro RS. Stanczyk FZ, et al. J Steroid Biochem Mol Biol. 2023 Jul;231:106289. doi: 10.1016/j.jsbmb.2023.106289. Epub 2023 Mar 25. J Steroid Biochem Mol Biol. 2023. PMID: 36972792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

527 results

Search Page